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Edited by Gerrit van MeerAbstract Recognition of lipid antigens by T lymphocytes is well
established. Lipids are recognized by T cells when presented in
association with CD1 antigen-presenting molecules. Both micro-
bial and self lipids stimulate speciﬁc T lymphocytes, thus partic-
ipating in immune reactions during infections and autoimmune
diseases. The immune system uses a variety of strategies to sol-
ubilise lipid antigens, to facilitate their internalization, process-
ing, and loading on CD1 molecules. Recent studies in the ﬁeld
of lipid antigen presentation have revealed new mechanisms
which allow the immune system to sense lipids as stimulatory
antigens.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Lipid transfer proteins1. Introduction
T lymphocytes recognize a large variety of antigenic mole-
cules, including short peptides, lipids and phosphorylated iso-
prene molecules. Recognition is exerted through interaction of
the T cell receptor (TCR) with a complex formed by the indi-
vidual ligand and a dedicated antigen presenting molecule. For
instance, peptides are recognized by the TCR when associated
with molecules encoded by the major histocompatibility com-
plex (MHC) that makes cognate interactions with both the
MHC and bound peptide. Also lipids are presented by dedi-
cated antigen-presenting molecules, which belong to the CD1
family and have a structure resembling that of MHC molecules
[1]. The crystal structures of CD1-lipid antigen complexes have
been solved in the last few years [2–9]. These studies have pro-
vided direct evidence of how T cells speciﬁcally recognize
hydrophobic lipid antigens [10].
The hydrophobic nature of lipids has forced the immune sys-
tem to utilize adequate mechanisms to allow lipid internaliza-
tion, endosomal localization, loading on CD1 molecules and
expression on the plasma membrane as immunogenic CD1
complexes. All of these diﬀerent steps, that together contribute
to antigen presentation to T cells, are the subject of this review*Corresponding author. Fax: +41 61 265 2350.
E-mail address: gennaro.delibero@unibas.ch (G. De Libero).
0014-5793/$32.00  2006 Federation of European Biochemical Soci
doi:10.1016/j.febslet.2006.08.029eties. Pu(Fig. 1). Recent ﬁndings, controversial issues and the aspects
which require additional studies are discussed.2. CD1 antigen-presenting molecules
CD1molecules are encoded on human chromosome 1 in a lo-
cus that is paralogous to that of MHC on chromosome 6. In
humans 5 CD1 genes exist (CD1A, CD1B, CD1C, CD1D
and CD1E) which have limited polymorphism, and share con-
siderable homology between each other [1]. This criterion has
been used to classify these molecules into two groups: CD1a,
b, and c are classiﬁed in Group 1, whereas CD1d is the only
member of Group 2. CD1e is not classiﬁed into these two
groups since it shows homology equally distant from groups
1 and 2 CD1 molecules. Mice and rats instead have only the
CD1D gene and therefore are not useful models to investigate
the immune response restricted by group 1 CD1 proteins.
CD1 are glycoproteins with a molecular weight of about
45 kDa forming heterodimeric structures by associating with
the 18 kDa b2-microglobulin. CD1 proteins are expressed by
professional antigen-presenting cells (APC), such as dendritic
cells (DC) and also by other cell types. In the thymus immature
thymocytes express all CD1 genes and are responsible for po-
sitive selection of CD1d-restricted developing T cells. Whether
group 1 CD1-restricted T cells are also selected by CD1 mole-
cules expressed by thymocytes is still open. In the periphery,
CD1d is expressed at diﬀerent levels by all hematopoietic cells,
whereas group 1 CD1 molecules have a more restricted cellular
distribution. Dendritic cells express all CD1 molecules [11],
whereas a subpopulation of human B lymphocytes express
CD1c [12]. CD1a is expressed at high levels by Langherans
cells [11], and CD1b is expressed by monocytes cultivated in
the presence of GM-CSF. This unusual distribution of CD1
antigen-presenting molecules restricts the capacity of present-
ing lipid antigens to some cells in the periphery and has impor-
tant consequences on lipid immunogenicity as well as on the
physiological role of anti-lipid responses. Moreover, the wide
distribution of CD1d is in contrast with the more selective
expression of other CD1 molecules and may contribute to a
diﬀerent function of CD1d-restricted T cells.
The crystal structures of human CD1a, b and d and mouse
CD1d have been solved (reviewed in [10]). All the molecules
are characterized by three domains with the a1 and a2
domains constituting the most distal part of the protein from
the membrane. The two domains show two antiparallel a
helices forming a deep and narrow groove in which the lipid
antigen is buried.blished by Elsevier B.V. All rights reserved.
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Fig. 1. Antigen presentation of lipids to T cells. (1) Lipoproteins are
internalized by speciﬁc receptors into early endosomes (EE, 2) where
the receptors dissociate and recycle on the cell surface, whereas (3)
lipids traﬃc to late endosomes/lysosomes (LE). (4) Bacteria are
phagocytosed and (5) accumulate in phagosomes (Ph) which fuse with
lysosomes. (3) In late endosomes/lysosomes complex lipids are further
processed and associate with CD1 presenting molecules. CD1-lipid
antigen complexes are then displayed on the cell surface. (6) Recog-
nition by speciﬁc T cell receptor (TCR) induces eﬀector functions
(interleukin secretion and killing of target cells).
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a non covalent manner with the b2-microglobulin partner. To-
gether they form a platform supporting the a1 and a2 domains
of CD1 molecules.
In all CD1 proteins a series of hydrophobic aminoacids form
hydrophobic pockets in which the alkyl chains of lipids are an-
chored. These pockets diﬀer in number and length in diﬀerent
CD1 molecules and thus contribute to lipid binding speciﬁcity.
For instance, the lipid binding site of CD1b consists of three
pockets (called A 0, C 0 and F 0), which merge in a central region
of the groove and by a fourth pocket (T 0 pocket) which in-
stead, acts like a tunnel and connects the A 0 and F 0 pockets.
This allows the insertion of very long hydrophobic lipid anti-
gens such as the mycobacterial mycolic acid that is composed
of 80 carbons. This structural feature is peculiar to CD1b be-
cause the T 0 pocket is closed in other CD1 molecules, which
therefore cannot bind very long lipid antigens.
CD1a is instead characterized by only two pockets with the
F 0 pocket partially open on its surface. This may allow the acyl
tail of bound antigens to protrude outside the binding groove
and perhaps to make cognate interactions with the TCR.
Some lipids, such as sulfatide, may also bind to all CD1 mol-
ecules and thus the repertoire of bound antigens is promiscu-
ous [13]. This increases the immunogenicity potential of
some lipid antigens.
The hydrophobic pockets merge in a common central cavity,
which is open on the CD1 surface. This open space allows the
insertion of the hydrophobic moieties inside the hydrophobic
pockets and also permits the hydrophilic part of the antigen
to remain between the two a helices and to stick out of
CD1. The unique surface composed by this hydrophilic moiety
and by aminoacids on the a helices provides precise contacts to
TCR, thus making the interaction highly speciﬁc [14,15].
CD1 a helices are also characterized by important residues,
which establish hydrogen bonds with the hydrophilic part of
lipid antigens and stabilize their orientation [3,5,8,10]. Thus,
they allow formation of complexes having a constant struc-
ture, which is a prerequisite for TCR recognition. These ami-
noacid residues behave as ‘‘tweezers’’, and their mutagenesishas dramatic consequences on T cell recognition (our own
unpublished studies).3. CD1 assembly and recycling
CD1 molecules assemble in the endoplasmic reticulum (ER)
where nascent molecules become non-covalently associated
with b2-microglobulin [16–18]. The assembly of CD1 mole-
cules is assisted by a variety of ER chaperones, such as caln-
exin, calreticulin and the thiol oxidoreductase Erp57. CD1d
is also assisted by the microsomal triglyceride transfer protein
(MTP) [19,20], which is involved in loading nascent ApoB with
lipid molecules and assembly of very low density lipoprotein
(VLDL) particles. The exact function of MTP in CD1d assem-
bly is not known. Perhaps, it participates in loading CD1d
with phosphatidylcholine, which has been found associated
in the CD1d crystal [6].
Recent experiments have revealed that CD1 molecules are
assembled together with spacer lipids which likely exert the
important function of stabilizers. Mouse CD1d contains a pal-
mytic acid in the A 0 pocket and a phosphatidylcholine mole-
cule, which instead inserts its acyl chains into the A 0 and F 0
pockets [8]. The length of the A 0 pocket is suﬃcient to contain
both lipids. Human CD1b instead contains a 42–44 carbons
long lipid which occupies part of the A 0 pocket, the T 0 and
the F 0 pocket [21]. In addition, it also contains one phosphati-
dylcholine molecule which inserts the two acyl chains in to the
remnant free space of the A 0 pocket and in the C 0 pocket.
These molecules resemble the peptides which become inserted
into and stabilize the binding groove of MHC class I molecules
during assembly in the ER. The stabilizing lipids are then ex-
truded, probably in late endosomes, where exogenous lipids
bind to CD1 molecules.
Human CD1d also forms supramolecular complexes with
MHC class II molecules and with the Invariant chain (Ii)
[22], whereas mouse CD1d has been found associated with Ii
[23]. These complexes acquire the capacity to traﬃc to late
endosomes where they localize in the luminal membranes of
multilamellar structures [24]. The cytoplasmic tail of Ii might
confer this unique type of traﬃcking.
An important feature distinguishing CD1 molecules is their
mode of recycling inside intracellular compartments (Fig. 2).
Upon ER assembly, CD1 molecules reach the cell surface pos-
sibly along the secretory pathway [25,26] and then are internal-
ized, with the exception of CD1e that always remains
intracellular [27]. CD1a is internalized in an ARF6-dependent
manner into early recycling endosomes and does not reach
lower endosomal compartments [28]. CD1c and human
CD1d traﬃc to late endosomes, with some CD1c molecules
only being internalized in early endosomes [28]. The cytoplas-
mic tail of CD1b associates with AP2 suggestive of a clathrin-
dependent internalization. CD1b and mouse CD1d also asso-
ciate with AP-3 and thus are conducted to late endosomes/
lysosomes [26,29–31]. The diﬀerent internalization capacity
may facilitate binding of diﬀerent lipid molecules present in
these compartments and thus diversify the repertoire of pre-
sented lipid antigens. Important diﬀerences are the luminal
pH of the endosomal compartments which also may aﬀect
CD1b loading and the presence of lipid transfer proteins
(LTP) which are present only in late endosomes/lysosomes.
CD1a CD1b CD1c CD1d CD1e
ER
Fig. 2. Diﬀerential traﬃcking of CD1 isoforms. CD1a traﬃcs to plasma membrane and is internalized in early recycling endosomes in an ARF6-
dependent manner. CD1b reaches the plasma membrane and is internalized in an AP-3 dependent manner into late endosomes/multilamellar
lysosomes and recycles on the cell surface. CD1c recycles in both early and late endosomes and recycles to cell surface from both compartments.
CD1d is internalized into late endosomes/lysosomes where it binds lipids and then recycles on the plasma membrane. CD1e does not reach the cell
surface. It accumulates in the Golgi of immature DC and, upon DC maturation, traﬃcs to late endosomes/lysosomes, where it is cleaved into a
soluble form.
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molecules inside endosomal membranes. CD1b and a fraction
of human CD1d localize to the limiting membrane of late
endosomes [32], whereas Ii-associated CD1d localizes to lume-
nal membranes of multivesicular bodies [24]. This latter distri-
bution is common to MHC class II molecules and has been
found necessary for their loading with peptide antigens [33].
Whether it is also important for loading CD1d with lipids
has not yet been investigated.4. The structure of immunogenic lipids
4.1. Self glycosphingolipids
Glycosphingolipids (GSL) and glycerophosphates have been
found capable of binding CD1 molecules and to stimulate spe-
ciﬁc T cells. In multiple sclerosis, an inﬂammatory autoim-
mune disease characterized by immune response against
myelin components, there is an increased number of circulat-
ing T cells recognizing diﬀerent self-GSL. Gangliosides
GM1, GT1b, GQ1b, GD1a can be presented by CD1b mole-
cules to speciﬁc T cells [34,35]. The autoreactive T cells release
pro-inﬂammatory cytokines and have a T helper 1 functional
phenotype, suggesting that they might be involved in the
inﬂammatory response in the brain. Indeed CD1 molecules
are expressed by astrocytes and macrophages present at the
borders of MS demyelinating plaques [36] and by astrocytes,
macrophages and B cells surrounding small vessels in the brain
of guinea pigs with experimental allergic encephalomyelitis
[37].
Interestingly T cells reacting to ganglioside GM1 also recog-
nize intact GT1b, GQ1b and GD1a [35], indicating that these
latter GSL may form complexes with CD1b in which the TCR
recognizes a common minimal epitope constituted by the ﬁve
sugars present in GM1.
Ganglioside GD3 has been found stimulatory for a popula-
tion of CD1d-restricted T cells in the mouse and participate in
rejection of melanoma cells, which release large amounts of
this ganglioside [38].
Sulfatide is another GSL abundant in myelin and serum that
stimulates speciﬁc T cells [13]. This GSL is the most immuno-
genic in MS and in these patients speciﬁc T cells are present athigh frequency (1:1000 of circulating CD4+ T cells, our
unpublished studies). Phosphoglycerolipids, such as phospha-
tidylinositol (PI), phosphatidylethanolamine (PE) and phos-
phatidylglycerol (PG) may stimulate CD1d-restricted T cells
[39]. Moreover, PC and PE extracted from cypresses pollens
may stimulate autoreactive T cells in allergic patients [40].
Some T cells cross-react with self phosphoglycerolipids and
this has been indicated as a possible cause of autoimmune
reactions in the lung.
A new mechanism has been recently described that may also
incite autoreactive lipid-speciﬁc T cells. Infection with both
gram-positive and gram-negative bacteria induces in infected
cells an increased synthesis and presentation of self lipids,
capable of activating self lipid-speciﬁc T cells [41]. This in-
duced recognition of self may deviate the immune response
against bacterial antigens. However, it may also represent an
important mechanism to induce autoimmunity without need
of antigen mimicry between bacterial and self antigens.
4.2. Bacterial lipid antigens
The response against lipids of microbial origin is an impor-
tant mechanism of immune defence. Most of the lipid antigens
identiﬁed so far are produced by Mycobacterium tuberculosis,
one of the most important pathogens in the world. A variety
of mycobacterial lipids stimulate human T cells and in most
of the cases these lipid antigens are presented by CD1b.
Mycolic acid is the ﬁrst microbial lipid discovered as a lipid
antigen [42]. It has a a-branched b-hydroxy long chain fatty
acid and the hydroxyl group is responsible for recognition by
T cells. In mycobacteria, mycolic acid is mostly covalently at-
tached to arabinogalactan and contributes to the surface of the
cell wall. Therefore, it is not a free antigen secreted by the sur-
viving intracellular bacilli.
Glucose monomycolate (GMM) was the second identiﬁed
immunogenic lipid [43] and is made of a mycolic acid attached
to a single glucose. Interestingly, mycobacteria use glucose of
host origin to synthesize GMM. Therefore, the immune re-
sponse against GMM might distinguish cells infected by path-
ogenic mycobacteria which persist inside infected cells whereas
do not recognize cells infected by innocuous environmental
mycobacteria which instead are rapidly eliminated and there-
fore do not accumulate GMM [44].
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noside (PIM) and lipoarabinomannan (LAM), are both made
of a phosphatidylinositol unit but diﬀer in their sugar parts.
PIM is composed of 2–6 mannoses and in some cases contains
a third and a fourth acyl chain. PIM2 (with two mannoses) is a
major constituent of the cell wall and is highly immunogenic
[45,46].
Lipoarabinomannan (LAM) is considered a virulence factor
and can be secreted in vivo by macrophages infected with M.
tuberculosis [47]. LAM is characterized by a very large glycan
composed of a polymannan backbone and branching matrix of
arabinan or arabinomannan. This large structure is presented
to T cells after internalization in late endosomes, where it is
likely processed and degraded to a smaller structure compati-
ble with CD1 binding and TCR interaction [45,48].
Sulfoglycolipids are another important constituent of the
mycobacterial cell wall. They are examples of the glycolipids
with short acyl chains and are typical of virulent mycobacteria.
Sulfoglycolipids are composed of a trehalose with up to four
acyl chains attached (mainly represented by palmytic, stearic
and hydroxyphthioceranoyl acid). A recently identiﬁed form
of sulfatide with only two acyl chains, also known as diacylsul-
phoglycolipid (Ac2SGL), represents a relevant immunogenic li-
pid during infection with M. tuberculosis [49].
Some mycobacterial antigens may have one lipid tail, such as
mannosyl-b-1-phosphomycoketide (MPM) [50,51]. This mole-
cule is composed of a single saturated alkane with methyl
branches on every fourth carbon resembling dolichol phos-
phate, which provides the scaﬀold of polysaccharide precursors
in eukaryotic cells. Indeed, some T cells speciﬁc for MPM
cross-react with endogenous dolichol phosphate molecules.
Other bacterial antigens stimulating human and mouse
CD1d-restricted T cells are produced by a-proteobacteria such
as Sphingomonas species. The stimulatory lipids are a-glucur-
onosylceramide and a-galacturonosylceramide [52–54]. Stimu-
lation of CD1d-restricted T cells also occurs during infections
with Ehrlichia muris, although the stimulatory molecules have
not been identiﬁed, yet. Neither Sphingomonas, nor E. muris
produce lipopolysaccharide (LPS) and therefore, the recogni-
tion of these bacterial products might represent an evolutionary
selected mechanism to react to LPS-deﬁcient microorganisms.
In addition to bacteria, parasites may also stimulate CD1-re-
stricted T cells. In a mouse model of infection with Leishmania
donovani, it was found that the lipoglycan (LPG) released by
these intracellular parasitesmay displaceCD1d-bound glycolip-
ids and stimulate a population of CD1d-restricted T cells [55].
4.3. Importance of lipid structure for immunogenicity
A large body of evidence have shown that the hydrophobic
parts participate in lipid immunogenicity. This may happen
through several mechanisms. In the model of ganglioside
GM1 recognition [35], the structure of the ceramide tail con-
tributes to speciﬁc TCR recognition. A lyso-GM1, as well as
the sugar component devoid of ceramide do not stimulate
GM1-speciﬁc T cells, most likely because these compounds
do not bind to CD1. The length of the acyl chain is also impor-
tant. Indeed, GM1 containing a C18 acyl chain is more stimu-
latory than the analogue bearing a C24 acyl chain (our
unpublished data). The opposite case occurs in the model of
sulfatide recognition: C24 analogues are more stimulatory
than C16 ones (our unpublished data), thus providing evidencethat association of short acyl chains with increased immunoge-
nicity is not a general rule. Both GM1 and sulfatide are pre-
sented by CD1b, thus excluding a diﬀerence due to the CD1
isoform and suggesting that the ﬁne speciﬁcity of the TCR is
instead relevant. Perhaps, the lipid tail length behaves as a
molecular ruler that places the orientation of the hydrophilic
head group, thus indirectly inﬂuencing TCR recognition. The
importance of the acyl chain structure was also identiﬁed in
recognition of PE [56]. T cells investigated in this study recog-
nized only PE containing at least one unsaturated acyl chain
and with a cis conﬁguration of double bonds. These structural
requirements most likely confer more eﬃcient binding to CD1.
Also the structure of the base in the ceramide of GSL,
namely the presence of double bonds and a-hydroxylation
may aﬀect immunogenicity [56]. These eﬀects might derive
from diﬀerences in the rigidity and polarity of the sphingoid
base that in turn might aﬀect the solubility of the lipid antigen.
The presence of a less rigid base may also alter the position in-
side the CD1 hydrophobic pockets, as occurs in the case of the
OCH a-galactosyl ceramide (a-GalCer) analogue that has a
very short sphingoid base [57,58]. This ligand has a fast oﬀ rate
from CD1d and therefore the stimulated T cells do not upreg-
ulate CD40 ligand, which is important for eﬃcient secretion of
the pro-inﬂammatory cytokine IFN-c [59]. The ﬁnal result is
preferential secretion of Interleukin-4 that is an anti-inﬂamma-
tory cytokine. This analogue has important immunomodula-
tory capacities in the mouse, as for example the inhibitory
eﬀects observed in development of experimental allergic
encephalomyelitis [57,58]. Several a-GalCer analogues have
been synthesized and recently investigated. The analogue con-
taining a diunsaturated C20 fatty acid (C20:2) potently induces
a T helper type 2 cytokine response, with diminished IFN-c
secretion and reduced expansion of Va 14 invariant NKT
(iNKT) cells [60]. On the contrary, the a-GalCer analogue with
a C-glycosidic bond preferentially induces pro-inﬂammatory
responses in Va14 iNKT cells, and enhances protection in ma-
laria infection and metastasis tumour models [61]. These eﬀects
might be exploited for the generation of appropriately modi-
ﬁed analogues to be used in diﬀerent therapeutic settings.
The importance of lipid structure may be even more relevant
during in vivo response against self lipids. In diﬀerent organs,
complex GSL are synthesised utilizing diﬀerent fatty acids
and therefore may strikingly diﬀer among each other. As
GSL diﬀering only in their acyl chains are discriminated by
T cells (our unpublished data), this may determine the tissue
localization of the inﬂammatory response following self lipid
recognition. The same applies to lipids synthesized inside the
thymus, which is the organ where T cells become tolerant to
self antigens. It is possible that the complex GSL synthesized
inside the thymus utilize fatty acids diﬀerent from those uti-
lized in other organs, thus allowing holes in the repertoire of
self antigens to which T cells become tolerant.5. Antigen presentation of lipids
5.1. Lipid antigen uptake
Internalization of exogenous lipid antigens is the ﬁrst impor-
tant step determining lipid immunogenicity. As lipids are not
water-soluble they are mostly associated with lipid binding
proteins in the serum.
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transport to CD1-positive antigen-presenting cells has been
identiﬁed [62]. This is achieved by internalization of lipopro-
tein particles containing ApoE, through speciﬁc interactions
with lipoprotein receptors, which also induce intracellular sig-
nalling. Another important function of ApoE is to bind myco-
bacterial lipids synthesized inside infected cells, thus permitting
the uptake of bacterial lipids by bystander CD1-positive APC.
This is an important mechanism in protection during myco-
bacterial infection because allows cross-presentation of bacte-
rial antigens by non-infected bystander cells [63].
Important issues remain to be investigated. For instance, it is
not clear whether other lipoproteins also contribute to immu-
nogenicity of exogenous lipids. Moreover, it is not clear
whether lipoprotein-mediated transport of exogenous lipids
to CD1-negative cells which express LDL receptors represents
a disposal mechanism and therefore contributes to inhibition
of lipid-speciﬁc response. Finally, it remains to be investigated
whether loss-of-function mutations in the LDL receptor gene,
which are the cause of familiar hypercholesterolemia, have
important eﬀects on internalization of lipid antigens and thus
reduce the antigen-presentation capacity of APC.
5.2. Lipid antigen traﬃcking
The way lipids traﬃc inside cells has important conse-
quences on association with CD1 molecules and presentation
to T cells. Internalization of plasma membrane lipids occurs
through diﬀerent routes. Sphingomyelin and sulfatide are
internalized through clathrin-coated vesicles, whereas lactosyl-
ceramide, globosides and gangliosides are internalized with
clathrin-independent mechanisms. These glycolipids rapidly
colocalize in an early sorting endosomal compartment together
with the transferrin receptor [64].
As diﬀerent CD1 molecules have diﬀerent traﬃcking capac-
ity, their intersection with internalized lipids determines which
lipids are more likely to be presented. CD1a is internalized into
clathrin-coated vesicles and recycles without reaching deeper
endosomal compartments [65]. This topological distribution
might explain why CD1a presents sulfatide and not ganglio-
sides, which instead are presented by CD1b [13,35]. However,
an abnormal internalization of glycolipids might occur during
phagocytosis of membrane debris. This is the case in degener-
ating plaques in the brain of multiple sclerosis patients, where
activated macrophages and DC phagocytose myelin. This
would allow intersection of CD1a with self lipids which usually
are internalized in CD1a-negative endosomal compartments
and might facilitate priming of non-tolerant CD1a-restricted
self lipid autoreactive T cells.
Lipid traﬃc might also aﬀect CD1 loading in late endo-
somes. This might occur at the level of the multivesicular
bodies (MVB) present in late endosomes where CD1b and
CD1d molecules localize [11]. The colocalization of these
CD1 molecules with lipids in the small vesicles of MVB might
facilitate lipid antigen processing and loading, as shown to be
the case with peptide antigens which are preferentially loaded
on MHC molecules with the same localization [33].
5.3. Lipid antigen processing and loading on CD1 molecules
Some lipid antigens require partial degradation, also called
processing, before they become immunogenic. The ﬁrst exam-
ple of GSL antigen processing was provided by investigatingthe response to the disaccharide Ga1-(a1-2)-GalCer [66]. This
synthetic glycolipid becomes immunogenic through removal of
terminal galactose exerted by the a-galactosidase enzyme
which is located in late endosomes.
Another lysosomal hydrolase, hexosaminidase B (HexB),
generates immunogenic isogloboside 3 (iGb3) after removal
of the terminal sugar from isogloboside 4 [67]. HexB-deﬁcient
mice are deﬁcient in iNKT cells, thus suggesting that this en-
zyme might be important in generating iGb3 and other ligands
required for iNKT cells selection in the thymus and expansion
in the periphery [67].
Although evidence is still lacking, it is very likely that lipases
are also involved in lipid antigen processing. Several bacterial
lipid molecules display more than two lipid tails, which is not
compatible with binding to CD1 molecules. Therefore, it is
anticipated that some of these molecules become antigenic
after removal of the lipid moieties preventing CD1 binding.
The mechanism of lipid antigen processing is facilitated by
lipid binding proteins present in late endosomes (Fig. 3A).
These are saposins (SAP), GM2 activator protein (GM2-A)
[68] and CD1e, whose importance in facilitating lipoglycan
digestion has been recently described [46]. Whether Nie-
mann-Pick type C 2 protein, which is also a lysosomal LTP,
participates in lipid antigen presentation is not known.
SAP are generated by digestion of the prosaposin precursor
and form homodimers that create a hydrophobic pocket allow-
ing lipid binding [69]. The functions of SAP and GM2-A are
overlapping and multiple. However, despite functional redun-
dancy in some cases individual LTP cannot be substituted by
other molecules.
LTP facilitate extrusion of lipid molecules facing the lume-
nal leaﬂet of small vesicles in MVB, which have a lipid compo-
sition diﬀerent from that of the endosomal limiting membrane.
MVB contain the negatively charged lipids bis-(monoacylgly-
cero)-phosphate and phosphatidylinositol-3-phosphate that
are required for lipid degradation. The small radius of MVB
and low lateral pressure allow LTP to insert inside MVB mem-
branes, to establish contact with negatively charged lipids and
behave as liftases which oﬀer GSL to hydrolases [70]. Upon
digestion, some lipid antigens are then transferred to CD1 mol-
ecules with the help of SAP and probably also of GM2-A [68].
Therefore, LTP participate in both the generation of immuno-
genic lipids and in their loading inside CD1 molecules. This
latter function seems facilitated by direct interaction of indi-
vidual SAP with CD1b [71] and CD1d molecules [68].
An important question is how the large variety of microbial
lipid antigens are processed and loaded on CD1 molecules,
being SAP and GM2-A limited in their lipid binding speciﬁc-
ity. Perhaps, LTP recognize structures shared among many dif-
ferent microbial lipids, thus always allowing presentation of
microbial-derived lipids during infection.
5.4. The function of CD1e
CD1e is another molecule that participates in lipid antigen
processing (Fig. 3B). CD1e is the ﬁfth member of CD1 family
and its function has been recently identiﬁed [46]. CD1e moves
into Golgi stack after assembly in the ER, and upon cell acti-
vation traﬃcs to late endosomes, without reaching the plasma
membrane [27]. Therefore, CD1e cannot present lipid antigens
to T cells. In late endosomes, it is cleaved and remains within
this compartment as a soluble molecule. CD1e facilitates diges-
?A B
sCD1e
MVB
CD1
SAP
CD1
Fig. 3. The function of lipid transfer proteins and CD1e. (A) Saposins (SAP) and GM2-activator protein extract glycolipids from luminal vesicles in
multivesicular bodies (MVB) and oﬀer them to hydrolases for digestion. Saposins are also involved in CD1 loading and unloading. (B) Soluble CD1e
(sCD1e) binds complex bacterial lipid antigens and oﬀers them to hydrolases for processing. Whether CD1e is also involved in loading other CD1
molecules is unknown.
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noses, into PIM2, that has only two mannoses [46]. In the ab-
sence of CD1e, PIM6 cannot be digested to PIM2 and therefore
is not recognized by speciﬁc T cells.
The model of CD1e structure [46] foresees an organization
into three domains, resembling the other CD1 proteins, but
also predicts some unique features. CD1e contains only one
large hydrophobic pocket formed by the merged A 0 and F 0
pockets, which might allow binding of a large variety of lipid
antigens. Moreover, the a1 helix is characterized by the ab-
sence of charged amino acids, a unique feature not found in
any other antigen-presenting molecule. This feature might
facilitate the interaction of CD1e with membranes and hydro-
phobic surfaces.
5.5. Half life of CD1-lipid antigen complexes
The immunogenicity of CD1-lipid antigen complexes is also
aﬀected by their half life. The prolonged exposition of the com-
plex on the surface of APC is necessary to allow interaction
with speciﬁc T cells. When the half life of complexes was mea-
sured on living DC, it was found that CD1a forms the most
persistent complexes surviving at least three days, whereas
CD1b and CD1c form complexes with a half life of 24 h
[13]. These diﬀerences cannot be ascribed to bound antigen, be-
cause each CD1 isoform was associated with sulfatide, but
rather depend on the internalization pattern of CD1 molecules.
Indeed, when CD1b is engineered with a CD1a cytoplasmic
tail, thus acquiring the same internalization pattern as CD1a,
it also forms very stable complexes with sulfatide (our unpub-
lished data). Thus, early endosomal localization confers a pro-
longed half life most likely as a consequence of the lack of
degrading enzymes and LTP in this intracellular compartment.5.6. Open issues and perspectives
Recent studies have further demonstrated the importance of
lipid-speciﬁc T cell recognition during immune response. These
investigations have revealed a series of biological mechanisms
which are mandatory for the generation of immunogenic lipids
and recognition by T cells. Several questions remain to be an-
swered and only some of the most important are illustrated
here.
The impact of CD1 polymorphism has not yet been assessed.
CD1 molecules have a limited polymorphism within the a2 do-
main. CD1e shows the highest number of polymorphic resi-
dues and the substitutions in CD1e might aﬀect the antigen-
binding pocket [72]. Thus, CD1e polymorphism might control
processing of microbial antigens and expand lipid-speciﬁc re-
sponses at the population level.
How lipid traﬃc inside endosomal compartments aﬀects li-
pid presentation is also relevant. How the exact localization
of CD1 molecules on the MVB or limiting membrane of late
endosomes inﬂuences lipid recognition awaits further experi-
mentation. A regulated membrane localization within these
organelles may have direct consequences on the type of loaded
lipids, on their persistence inside CD1 molecules and thus on
the immunogenicity of individual lipids.
A third important aspect is the possible use of lipids as novel
components in subunit vaccines. Preliminary experiments in a
tuberculosis model in guinea pigs have shown that immuniza-
tion with a crude lipid extract fromM. tuberculosis may reduce
bacterial burdens in the lung and spleen and induces signiﬁ-
cantly less pathology [73]. Therefore, it will be important to
investigate whether immunization with individual synthetic lip-
ids selected for their immunogenicity leads to improved protec-
tion.
5586 G. De Libero, L. Mori / FEBS Letters 580 (2006) 5580–5587In conclusion, all these studies are providing new examples
of the extreme ﬂexibility of the immune system in antigen rec-
ognition. In a more general context they are also disclosing
new important and unexpected biological functions of lipids.
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